Cocrystal Pharma, Inc. (COCP) vs Kyntra Bio Inc (KYNB)
- Cocrystal Pharma, Inc. COCP 1.02 −0.97%
- Kyntra Bio Inc KYNB 4.85 −9.51%
Cocrystal Pharma, Inc. and Kyntra Bio Inc are both Biotechnology companies. Cocrystal Pharma, Inc. and Kyntra Bio Inc are of similar size ($21.7M and $19.8M). Cocrystal Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Cocrystal Pharma, Inc. grew revenue faster over the last twelve months: −30.4% against −37.2%. Kyntra Bio Inc has the higher net margin (3,967.8% vs −747.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Cocrystal Pharma, Inc. leads on 8 and Kyntra Bio Inc on 7.
Valuation
Profitability
| Metric | COCP | KYNB | Biotechnology median |
|---|---|---|---|
| Gross margin | 9.10% | 6.28% | 65.16% |
| Operating margin | (760.72%) | (1,089.78%) | 0.00% |
| Net margin | (747.78%) | 3,967.77% | 0.00% |
| Free cash flow margin | (598.50%) | (824.19%) | 0.00% |
| Return on equity | (311.68%) | (157.83%) | (56.36%) |
| Return on assets | (151.10%) | 131.26% | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack